Evidence map›Paper›PMID 37252342›Full record

ArticleFrontiers in bioinformatics2023

Application of annotation-agnostic RNA sequencing data analysis tools for biomarker discovery in liquid biopsy.

Gabriel Wajnberg, Eric P Allain, Jeremy W Roy, Shruti Srivastava, Daniel Saucier, Pier Morin, Alier Marrero, Colleen O'Connell, Anirban Ghosh, Stephen M Lewis and 2 more

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gabriel WajnbergAtlantic Cancer Research Institute, Moncton, NB, Canada.
Eric P AllainAtlantic Cancer Research Institute, Moncton, NB, Canada.
Jeremy W RoyAtlantic Cancer Research Institute, Moncton, NB, Canada.
Shruti SrivastavaAtlantic Cancer Research Institute, Moncton, NB, Canada.
Daniel SaucierDepartment of Chemistry and Biochemistry, Université de Moncton, Moncton, NB, Canada.
Pier MorinDepartment of Chemistry and Biochemistry, Université de Moncton, Moncton, NB, Canada.
Alier MarreroDr. Georges-L.-Dumont University Hospital Centre, Moncton, NB, Canada.
Colleen O'ConnellStan Cassidy Centre for Rehabilitation, Fredericton, NB, Canada.
Anirban GhoshAtlantic Cancer Research Institute, Moncton, NB, Canada.
Stephen M LewisAtlantic Cancer Research Institute, Moncton, NB, Canada.
Rodney J OuelletteAtlantic Cancer Research Institute, Moncton, NB, Canada.
Nicolas CrapouletAtlantic Cancer Research Institute, Moncton, NB, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA sequencing analysis is an important field in the study of extracellular vesicles (EVs), as these particles contain a variety of RNA species that may have diagnostic, prognostic and predictive value. Many of the bioinformatics tools currently used to analyze EV cargo rely on third-party annotations. Recently, analysis of unannotated expressed RNAs has become of interest, since these may provide complementary information to traditional annotated biomarkers or may help refine biological signatures used in machine learning by including unknown regions. Here we perform a comparative analysis of annotation-free and classical read-summarization tools for the analysis of RNA sequencing data generated for EVs isolated from persons with amyotrophic lateral sclerosis (ALS) and healthy donors. Differential expression analysis and digital-droplet PCR validation of unannotated RNAs also confirmed their existence and demonstrates the usefulness of including such potential biomarkers in transcriptome analysis. We show that find-then-annotate methods perform similarly to standard tools for the analysis of known features, and can also identify unannotated expressed RNAs, two of which were validated as overexpressed in ALS samples. We demonstrate that these tools can therefore be used for a stand-alone analysis or easily integrated into current workflows and may be useful for re-analysis as annotations can be integrated

Indexed as

annotation-agnosticbiomarkersextracellular vesiclesgenetic diseasesliquid biopsyquantification algorithmssmall RNA

Identifiers

PMID37252342
PMCPMC10213969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.